Expert Pitch
University of Delaware

COVID-19: Disaster researchers can comment on infants, at-risk populations, chronically ill and animals

16-Mar-2020 4:50 PM EDT, by University of Delaware

The University of Delaware's Disaster Research Center includes several core faculty members who can discuss various aspects of the COVID-19 health crisis:

Sarah DeYoung, Assistant Professor of Sociology and Criminal Justice: Can talk about companion animals and COVID-19, as well as how animal shelters are pushing fostering now and how during financial turmoil there could be mass animal surrenders (and possibly more euthanasia). She can also discuss infant feeding and food insecurity during disasters.

James Kendra, co-director of the Disaster Research Center and Professor of Public Policy: Expert on communications, crisis leadership and stigmatization of certain populations in health emergencies.

Joseph Trainor, Associate Professor of Public Policy: Can discuss the risk communication challenges of COVID-19, in particular the difficulty of navigating multiple, changing and conflicting streams of information. Also, recently researched how to support emergency service workers so they are able to come to work.

Jennifer Trivedi, Assistant Professor of Anthropology: Can speak to the importance of ensuring people who are financially, housing or food insecure are taken care of and about the potenially high-risk impact for the disabled and chronically ill. She can also talk about how COVID-19 and disasters more broadly can be incorporated into classes to both let students share their experiences and because it ties into so many different issues. 

Tricia Wachtendorf, co-director of the Disaster Research Center and Professor of Sociology: Can speak to aspects of how people might engage in volunteer, improvised and emergent efforts in response to COVID-19 and disasters more broadly. She can also discuss how people may be impacted in different ways, social stigma, aspects of response and coordination and decision-making




Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.


Showing results

110 of 2539

close
2.99335